Weaver C. Barksdale & Associates, Inc. / MET
Weaver C. Barksdale & Associates, Inc.’s Metlife Inc Position
Does Weaver C. Barksdale & Associates, Inc. own Metlife Inc (MET)? Yes — 22.0K shares worth $2M (+1.49% of its 13F portfolio) as of Q1 2026, up from 20.8K shares the prior filed quarter.
Position Value
$2M
Q1 2026
Shares
22.0K
% of Portfolio
+1.49%
Quarters Held
18
currently held
Position History MET
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 22.0K | $2M | +1.49% |
| Q4 2025 | 20.8K | $2M | +1.72% |
| Q3 2025 | 23.5K | $2M | +1.86% |
| Q2 2025 | 25.0K | $2M | +1.92% |
| Q1 2025 | 25.2K | $2M | +1.94% |
| Q4 2024 | 25.8K | $2M | +2.02% |
| Q3 2024 | 26.5K | $2M | +1.97% |
| Q2 2024 | 27.4K | $2M | +1.83% |
| Q1 2024 | 27.9K | $2M | +1.90% |
| Q4 2023 | 28.1K | $2M | +1.82% |
| Q3 2023 | 35.3K | $2M | +1.89% |
| Q2 2023 | 29.8K | $2M | +1.66% |
| Q1 2023 | 31.6K | $2M | +1.71% |
| Q4 2022 | 33.1K | $2M | +2.11% |
| Q3 2022 | 32.3K | $2M | +1.97% |
| Q2 2022 | 33.4K | $2M | +1.95% |
| Q1 2022 | 31.4K | $2M | +1.97% |
| Q4 2021 | 31.0K | $2M | +1.76% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Weaver C. Barksdale & Associates, Inc.’s full portfolio or all institutional holders of MET.